# Nicolas Godin

> Nicolas Godin is a pre-seed investor at Cardiologs (Paris) backing Health Care and Biotechnology. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Cardiologs](https://shizune.co/investors/profile/cardiologs)
- Location: Paris, France
- Total investments: 3
- Last investment: Sep 2022
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/nicolas-godin-529abb15/
- X (Twitter): https://twitter.com/nclasgodin
- Website: https://x.com/nclasgodin

Nicolas Godin is a pre-seed investor at Cardiologs in Paris focused on Health Care and Biotechnology. In addition to managing the company’s finances, Nicolas is responsible for Cardiologs’ operations and is a key voice on a variety of strategic and operational matters. Nicolas holds an MSc in Civil Engineering and an MBA from INSEAD, and started his career at PwC Transaction Services, working intensively on large European M&A deals. After anexperience at a VC fund in Paris, he joined the EdTech startup Coorpacademy, where he managed a Series B fundraising and transformed the company into a true SaaS business. Excited by the cross-functional nature of his role, Nicolas brings operational and financial excellence to Cardiologs.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 67% |
| Biotechnology | 2 | 67% |
| Machine Learning | 1 | 33% |
| Predictive Analytics | 1 | 33% |
| Artificial Intelligence | 1 | 33% |

6 industries tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| France | 1 | 33% |
| United States | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Surge | Surge is an immunological model capable of predicting postoperative infections. The company combines a single-cell assessment of the immune system before surgery with clinical data using a proprietary machine-learning algorithm. By analyzing the millions of immune cells in a small amount of blood, the platform can mimic surgical trauma in a testtube before surgery. | $2.6M | Pre-Seed | Sep 22, 2022 |  |
| Surge | Surge operates as a biotech company focused on optimizing treatment for patients undergoing surgery. |  | Pre-Seed | Sep 02, 2022 |  |
| Surge | Surge is an immunological model capable of predicting postoperative infections. The company combines a single-cell assessment of the immune system before surgery with clinical data using a proprietary machine-learning algorithm. By analyzing the millions of immune cells in a small amount of blood, the platform can mimic surgical trauma in a testtube before surgery. |  | Pre-Seed | Sep 01, 2022 |  |

3 of 3 investments shown.

## Co-investors
- [Boutique Venture Partners](https://shizune.co/investors/profile/boutique-venture-partners) — VC Fund, 3 deals together
- [HCVC](https://shizune.co/investors/profile/hardwareclub) — VC Fund, 3 deals together

## About Cardiologs

VC Fund · Paris, France

Cardiologs is a medical technology company that uses medical-grade AI and cloud technology, transforming cardiac diagnostics. The first company's product, The Cardiologs Holter solution is built on a proprietary database of more than 18,000,000 recordings growing exponentially and is supported by a number of clinical publications thatdemonstrate leading diagnostic performance. It is powered by the 1st deep learning technology to receive regulatory clearance. Founded in 2014, Cardiologs partners with clinicians and healthcare practitioners to realize the vision of making expert cardiac diagnostics scalable, and accessible to everyone.

5 contacts available at Cardiologs.

| Name | Title | Profile |
| --- | --- | --- |
| Jean-Patrice Anciaux | Board Member | https://shizune.co/investors/profile/jean-patrice-anciaux |
| Nicolas Godin | COO | https://shizune.co/investors/profile/nicolas-godin |
| Anne Osdoit | Independent Board Director | https://shizune.co/investors/profile/anne-osdoit |
| Gaelle Salaun | Regulatory and Quality Manager | https://shizune.co/investors/profile/gaelle-salaun |
| Jia Li | CSO & Co-Founder | https://shizune.co/investors/profile/jia-li-2 |

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Everywhere Ventures](https://shizune.co/investors/profile/everywhere-ventures) — VC Fund

### Similar country
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [Kima Ventures](https://shizune.co/investors/profile/kima-ventures) — VC Fund
- [Motier Ventures](https://shizune.co/investors/profile/motier-ventures) — VC Fund

## Featured in investor lists
- [Biotechnology Angel Investors in France](https://shizune.co/investors/biotechnology-angel-investors-france)
- [Biotech Angel Investors in France](https://shizune.co/investors/biotech-angel-investors-france)

## FAQ

### What does Nicolas Godin invest in?

Nicolas Godin invests primarily in Health Care, Biotechnology and Machine Learning startups, most often at Pre-Seed stage. Most of the 3 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Nicolas Godin last invest?

The most recent investment recorded for Nicolas Godin closed in Sep 2022. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co